Drug Name:
MONISTAT 1 COMBINATION PACK OTC
Generic Name and Formulations:
Miconazole 1200mg (vaginal supp), miconazole nitrate 2% (topical crm).
Company:
Prestige Brands, Inc.
Therapeutic Use:
Indications for MONISTAT 1 COMBINATION PACK:
Vulvovaginal candidiasis.
Adult:
Insert 1 supp vaginally once at bedtime. Crm: apply twice daily as needed for up to 7 days.
Children:
Not recommended.
Warnings/Precautions:
Use of contraceptive diaphragm or condoms within 3 days, or use of tampons, douches, or spermicides within 7 days: not recommended. Confirm diagnosis by KOH smears +/or cultures. If ineffective, reconfirm diagnosis before repeating therapy. Discontinue if irritation occur. 1st trimester of pregnancy. Nursing mothers.
Pharmacological Class:
Azole antifungal.
Interactions:
May potentiate warfarin.
Adverse Reactions:
Vulvovaginal burning, itching or irritation; edema, cramps, nausea, headache, rash, urticaria.
How Supplied:
Combination Pack—1x1200mg supp (w. applicator or prefilled applicator) + 9g topical crm
Sign Up for Free e-newsletters
ONA Articles
- Adhering to Cytoreductive Therapy Use May Improve Outcomes in Polycythemia Vera
- FDA, EU Approvals Sought for Split Dose Regimen of Daratumumab for Multiple Myeloma
- Alternate Dosing of Ruxolitinib May Alleviate Anemia in Myelofibrosis
- Hope, Gratitude, and Spirituality: What They Mean to Cancer Patients
- Combined Digital Screening Best for Detecting Breast Cancers
- NCCIH HerbList App Launched to Provide Information on Herbal Products
- Seeking Reliable Information on Herbal Products
- Metformin Use May Improve Survival Outcomes in Bladder Cancer
- Higher Vitamin D Levels Associated With Lower Breast Cancer Risk
- Nurse-Led Program Improves Health, Financial Outcomes in Outpatient Chemotherapy
- The Efficacy and Tolerance of High Pressure Oxygen Combined With Chemotherapy in Postoperative Patients With Advanced Gastric Cancer
- Hepatocellular Cancer Pain: Impact and Management Challenges
- Serum Albumin May Indicate Prognosis for Survival in Acute Myeloblastic Leukemia
- Nonmyeloablative/Reduced-Intensity Conditioning May Reduce Mucositis in HCT
- Alternate Dosing of Ruxolitinib May Alleviate Anemia in Myelofibrosis
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |